Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194960 | SCV000247549 | uncertain significance | not specified | 2014-09-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000194960 | SCV000603950 | likely benign | not specified | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000194960 | SCV000716651 | likely benign | not specified | 2017-03-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000638561 | SCV000760088 | benign | Methylmalonic acidemia with homocystinuria, type cblX | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003947606 | SCV004758707 | likely benign | HCFC1-related condition | 2019-02-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000194960 | SCV001929518 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726038 | SCV001964128 | likely benign | not provided | no assertion criteria provided | clinical testing |